The global chronic wound care market is expanding as aging populations and rising rates of diabetes and obesity increase the number of patients with wounds that do not heal on their own, according to Kings Research. The market was valued at USD 11.17 billion in 2022 and is projected to reach USD 15.51 billion by 2030, growing at a CAGR of 4.28% from 2023 to 2030. Advanced dressings, home-based therapies, and digital support tools are reshaping how these conditions are treated.
Market Overview
The main objective of wound care is to promote healing and prevent infection through dressings and local or systemic treatment. Faster and more complete wound closure improves quality of life, reduces pain and discomfort, and lowers the risk of complications such as infection, and effective treatment can reduce the overall cost of caring for these patients.
Chronic wounds typically result from a predisposing disease that affects dermal and epidermal tissue integrity. Leg ulcers, foot ulcers, and pressure sores may develop from poor arterial supply or venous drainage, as well as from metabolic illnesses such as diabetes mellitus. Treatment calls for a multidisciplinary approach that combines medical, surgical, and therapeutic interventions, with growing attention to prevention, early detection, and timely intervention.
The World Health Organization has recognized chronic wounds as a major global problem and recommends greater awareness, attention to socioeconomic and cultural factors, and investment in wound care research. Several nanotechnologies with properties suited to specific wound care problems are also fostering market growth.
Key Findings from the Report
- The market was valued at USD 11.17 billion in 2022 and is projected to reach USD 15.51 billion by 2030.
- Diabetic ulcers were the dominant type, with a market value of USD 4.33 billion in 2022.
- Advanced wound dressings led by product with USD 6.12 billion in 2022 and are projected to reach USD 8.33 billion by 2030.
- The homecare settings segment is expected to grow to USD 5.65 billion during the forecast period.
- North America held a 43.24% share in 2022, valued at USD 4.83 billion.
- Asia Pacific is the fastest-growing region, with a CAGR of 5.33% and a forecast value of USD 3.16 billion.
Market Dynamics: Chronic Disease and an Aging Population
Demand for chronic wound care has increased in recent years because of an aging population and a rise in chronic diseases such as diabetes and cardiovascular disease. According to the International Diabetes Federation, diabetes affected around 537 million people aged 20 to 79 in 2021, and the number is expected to reach 643 million by 2030 and 783 million by 2045. The World Health Organization also notes that cardiovascular diseases are among the most common causes of death worldwide, claiming an estimated 17.9 million lives annually.
These trends are creating demand for chronic wound services. Effective wound care can deliver faster healing, better patient satisfaction, and improved outcomes. Demand is also influenced by healthcare infrastructure, policy, and reimbursement systems. In some countries, geographic or economic barriers limit access to wound care, while in others there is a shortage of professionals with specialized wound care skills. Changes in healthcare policy and reimbursement are significantly shaping demand for these services, even as continued research and development of healing strategies and therapies drives progress.
Market Challenges
The complications and high costs associated with advanced products restrict market growth. Evidence-based wound care is expensive, and it can be difficult for patients to access professional wound management. In addition, the treatment of burn injuries remains a major challenge. Although many advanced techniques exist to support chronic wound healing and stimulate tissue regeneration, many rely on harvested natural tissues. As research expands, new strategies and treatments are emerging that aim to improve healing and reduce healthcare costs.
Analyst’s Review
The market is growing quickly because effective treatment requires a multidisciplinary approach that stresses prevention, early detection, and timely intervention. A recent focus on wound care research has accelerated the need for advanced wound dressings. Smart wound care facilities and the growing use of artificial intelligence are additional contributors, and the development of smart bandages is helping to address different kinds of wounds at low cost.
Segmentation Analysis
By type, the market is divided into diabetic ulcers, pressure ulcers, venous ulcers, and others. Diabetic ulcers are the most dominant segment, with a market value of USD 4.33 billion in 2022, a result of the growing number of diabetic patients worldwide and the availability of technologically advanced wound care products.
By product, the market includes advanced wound dressings, wound care therapy, active therapy, and others. Advanced wound dressings held the largest share with USD 6.12 billion in 2022, driven by smart wound care facilities and growing use of artificial intelligence. By end user, the market is categorized into hospitals and wound care centers, homecare settings, and others. Homecare is expected to grow to USD 5.65 billion during the forecast period. Homecare wound treatment began primarily with single-use negative pressure wound therapy systems, which are light, portable, easy to use, and cost-effective, encouraging patients to adopt care at home.
Regional Analysis
North America held a 43.24% share in 2022, valued at USD 4.83 billion. Population growth across the region has increased the focus of healthcare providers on wounds such as diabetic foot ulcers and chronic venous leg ulcers, which can lead to serious consequences including foot amputation. According to the American Academy of Home Care Medicine in April 2023, about 6.5 million people, or roughly 1 in 38 adults, are affected by chronic wounds each year in the United States. The availability of advanced wound care products for critical cases has accelerated regional revenue.
Asia Pacific is the fastest-growing region, with a CAGR of 5.33% and a forecast value of USD 3.16 billion. A growing incidence of diabetes and cardiovascular disease requires effective wound care, and the need to prevent infections and improve healing rates is leading to better patient outcomes and lower healthcare costs. The World Health Organization has identified wound care as a priority area, and organizations are working to improve access to wound care services and build infrastructure in the region. Telemedicine and remote monitoring offer promising solutions for patients in peripheral areas, while researchers focus on nanotechnology-based therapeutic agents and evaluate their efficacy in diabetic models of chronic wound healing. Healthcare providers and policymakers continue to address infrastructure gaps, differences in health policies, and language and cultural barriers.
Competitive Landscape
The market is highly fragmented. Major players are focusing on partnerships, mergers and acquisitions, product innovation, and joint ventures to expand their portfolios and increase market share across regions. Expansion and investment efforts include research and development, new manufacturing facilities, and supply chain optimization.
Key companies profiled include 3M, B. Braun SE, Cardinal Health, Coloplast A/S, Colzyx AB, Convatec Inc., Integra LifeSciences, Kane Biotech Inc., Medline Industries, Inc., and Smith+Nephew.
Recent Developments
- In April 2023, Kane Biotech announced a distribution agreement with ProgenaCare Global for its coactive antimicrobial wound gel in the U.S. wound care and surgical markets, focusing on affordable and effective technologies.
- In July 2022, Smith+Nephew released WOUND COMPASS, a clinical support app that helps clinicians with wound assessment and decision-making to reduce variation in practice.
- In January 2022, Colzyx developed a wound care technology that inhibits bacterial growth while aiding healing, with the potential to change future chronic wound management.
Strategic Implications for Stakeholders
For manufacturers, the report indicates that advanced dressings and home-compatible therapies are the core commercial opportunities, and that products linked to digital decision support or smart monitoring may be better placed to demonstrate value. For hospitals and wound care centers, the shift toward homecare suggests a need for coordinated discharge pathways, remote follow-up, and clinician training. For payers and policymakers, the link between effective wound care and lower overall treatment costs strengthens the case for earlier intervention and prevention, especially in diabetic populations where complications such as amputation carry heavy human and financial costs. For emerging markets, telemedicine and remote monitoring can help extend scarce specialist capacity to patients in peripheral areas, provided that infrastructure and affordability barriers are addressed. Ultimately, success in this market will depend on aligning product innovation with the realities of care delivery: cost, ease of use, and the ability to show better healing outcomes in the settings where patients are actually treated.
Outlook
Chronic wound care is a market where clinical need is clear and growing. Diabetes prevalence, population aging, and cardiovascular disease will keep generating patients, and advanced dressings will account for the largest share of revenue by 2030. Home-based care is likely to become more important as portable, single-use therapy systems and remote monitoring reduce the burden on hospitals. Asia Pacific offers the fastest growth, though infrastructure and access challenges will need to be addressed. Companies that pair clinically proven products with digital decision support and affordable pricing are well placed to benefit.
The full Kings Research report, released in June 2023 and spanning 120 pages, offers deeper analysis of the market’s segments, regions, and competitors.
About Kings Research
Kings Research is a market research and consulting firm, part of One Media Group, that delivers data-driven intelligence and strategic guidance to help organizations identify, evaluate, and capitalize on market opportunities across industries. Its reports combine quantitative market sizing with qualitative analysis of drivers, challenges, trends, regulatory frameworks, and competitive landscapes.
Media Contact: Kings Research, 5348 Vegas Dr. Suite 305, Las Vegas, NV 89108. Email: business@kingsresearch.com